A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors

Peer Review reports

Original Submission
16 Jun 2023	Submitted	Original manuscript
13 Sep 2023	Reviewed	Reviewer Report - Barbara Ziółkowska
12 Oct 2023	Reviewed	Reviewer Report
7 Nov 2023	Author responded	Author comments - Aino Rönkä
Resubmission - Version 2
7 Nov 2023	Submitted	Manuscript version 2
22 Nov 2023	Reviewed	Reviewer Report
23 Nov 2023	Reviewed	Reviewer Report - Barbara Ziółkowska
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
30 Nov 2023	Editorially accepted
4 Dec 2023	Article published	10.1186/s12885-023-11699-0

Back to article page